Brought to you by

October 27, 2014 Issue:

Recent Health Care M&A Deals







Meridian Health

Hackensack University
Health Network





Apricus Biosciences

License to fispemifene

$12.5 million

Takeda Pharmaceutical Company Limited

License to AMITIZA

$14 million

Ferring Pharmaceuticals

Rights to DDAVP



googletag.cmd.push(function() { googletag.display(‘div-hcdn-leader-1’); });


Genentech Licenses Promising Cancer Treatment
NewLink Genetics Corporation of Ames, Iowa sold the worldwide license for the development of NLG919, an IDO pathway inhibitor that is currently in Phase 1 trials. The buyer was the Roche Group’s (SIX: RO) biotech subsidiary Genentech, which paid $150 million upfront. If all goes well, it will fund future research, development, manufacturing and commercialization outside the United States. NewLink retains the option for co-promotion rights and potential next-generation IDO/TDO compounds in the United States.

googletag.cmd.push(function() { googletag.display(‘div-hcdn-leader-2’); });


Busiest Acquirers in Q3:14
It’s one thing to put together a big deal, and it’s another to put together several deals in a quarter.  In the third quarter, 274 companies were involved in the 326 transactions in as buyers. Publicly traded corporations announced 169 deals, valued at $112.6 billion. Here’s the list of serial acquirers from The Health Care M&A Report, Third Quarter, due out this week. 
Acquirers with Three or More Deals, Q3:14




The Ensign Group, Inc.

Long-Term Care


American Realty Capital Healthcare Trust-II

Long-Term Care


IPC The Hospitalist Company

Physician Medical Groups


TeamHealth Holdings

Physician Medical Groups


Capitol Seniors Housing

Long-Term Care


Medtronic, Inc.

Medical Devices


Sanofi SA



Source: The Health Care M&A Information Source, October 24, 2014

googletag.cmd.push(function() { googletag.display(‘div-hcdn-leader-3’); });


Doctor Groups Are Hot Commodities
Physician Medical Groups were hot commodities last week, not just in the third quarter (see chart above). At least three transactions were announced by the publicly traded practice management companies. TeamHealth Holdings (NYSE: TMH) acquired Premier Physician Services which is based in Dayton, Ohio and has operations in six other states. This is its eighth acquisition since September.  IPC The Hospitalist Company (NASDAQ: IPCM) expanded into the Philadelphia market with the acquisition of Comprehensive Health Solutions, which provides acute and post-acute care to about 13,000 patients on an annual basis. MEDNAX, Inc. (NYSE: MD) on-boarded Houston Perinatal Associates, and DaVita HealthCare Partners (NYSE: DVA) acquired Colorado Springs Health Partners, a multi-specialty medical group with more than 100 physicians in 11 locations around the Pikes Peak region. 

googletag.cmd.push(function() { googletag.display(‘div-hcdn-leader-4’); });

J&J Moves Innovation to Houston
Johnson & Johnson (NYSE: JNJ) is not content to keep its biotech innovation centers on the coasts (California and Massachusetts). Last week the company announced the opening of J-Labs @TMC in Houston, where it will work with the Texas Medical Center. The new 30,000 square foot incubator will be housed in TMC’s Innovation Institute and is expected to open in 2015. J&J hopes to host up to 50 life sciences startups there………Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

googletag.cmd.push(function() { googletag.display(‘div-hcdn-leader-5’); });

Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Investor Conferences…Click here to see more
Previous Issues of Health Care Deal News…Click here to see more